Neuroendocrine and oxidoreductive mechanisms of stress-induced cardiovascular diseases

Physiological Research

Volumn 57, Issue 3, 2008, Pages 327-338

  Pajović, Snežana B ^a   Radojcic M B ^a   Kanazir, D T ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b SERBIAN ACADEMY OF SCIENCES AND ARTS   (Serbia)

Author keywords

Cardiovascular diseases; Neuroendocrine response; Oxidative stress

Indexed keywords

ANTIOXIDANT; HEAT SHOCK PROTEIN; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

ANIMAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DIET; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIFESTYLE; METABOLISM; NEUROSECRETION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHOSPHORYLATION; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; STRESS;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIET; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HUMANS; LIFE STYLE; NEUROSECRETORY SYSTEMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASES; REACTIVE OXYGEN SPECIES; RISK ASSESSMENT; RISK FACTORS; STRESS;

EID: 45849115516     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (73)

1. ALLEN RG: Oxygen-reactive species and antioxidant responses during development: the metabolic paradox of cellular differentiation. Proc Soc Exp Biol Med 196: 117-129, 1991.
2. ALLEN RG: Oxidative stress and superoxide dismutase in development, aging and gene regulation. Age 21: 47-76, 1998.
3. ALLEN RG, TRESINI M: Oxidative stress and gene regulation. Free Rad Biol Med 28: 463-499, 2000.
4. BAKER PJ, RAMEY ER, RAMWELL PW: Androgen-mediated sex differences of cardiovascular responses in rats. Am J Physiol 235: H242-H246, 1978.
5. BARRETT-CONNOR E: Cardiovascular endocrinology 3: an epidemiologist looks at hormones and heart disease in women. J Clin Endocrinol Metab 88: 4031-4042, 2003.
6. BENJAMIN IJ, MCMILLAN DR: Stress (heat shock) proteins-molecular chaperons in cardiovascular biology and disease. Circ Res 83: 117-132, 1998.
7. BESSE S, BULTEAU AL, BOUCHER F, RIOU B, SWYNGHEDAUW B, DE LEIRIS J: Antioxidant treatment prevents cardiac protein oxidation after ischemia-reperfusion and improves myocardial function and coronary perfusion in senescent hearts. J Physiol Pharmacol 57: 541-552, 2006.
8. 2) increases the steady-state mRNA level of collagenase/MMP-1 in human dermal fibroblasts. Free Radic Biol Med 22: 515-524, 1997.
9. BRUNDEL BJ, SHIROSHITA-TAKESHITA A, QI X, YEH YH, CHARTIER D, VAN GELDER IC, HENNING RH, KAMPINGA HH, NATTEL S: Induction of heat shock response protects the heart against atrial fibrillation. Circ Res 99: 1394-1402, 2006.
10. CADENAS E: Biochemistry of oxygen toxicity. Annu Rev Biochem 58: 79-110, 1989.
11. CHOI AMK, PIGNOLO RJ, RHYS CMJ, CRISTOFALO VJ, HOLBROOK NJ: Alterations in the molecular response to DNA damage during cellular aging of cultured fibroblasts: reduced AP-1 activation and collagenase gene expression. J Cell Physiol 164: 65-73, 1995.
12. CHOJKIER M, HOUGLUM K, SOLIS-HERRUZO J, BRENNER DA: Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. J Biol Chem 264: 16957-16962, 1989.
13. COTGREAVE IA., MOLDEUS P, ORRENIUS S: Host biochemical defense mechanisms against prooxidants. Pharmacol Toxicol 28: 189-212, 1988.
14. CROWN A, LIGHTMAN S: Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol 63: 483-492, 2005.
15. DAS S, O'KEEFE JH: Behavioral cardiology: recognizing and addressing the profound impact of psychosocial stress on cardiovascular health. Curr Atheroscler Rep 8: 111-118, 2006.
16. DHALLA NS, TEMSAH RM, NETTICADAN T: Role of oxidative stress in cardiovascular diseases. J Hypertens 18: 655-673, 2000.
17. FANG YZ, YANG S, WU G: Free radicals, antioxidants and nutrition. Nutrition 18: 872-879, 2002.
18. FEIL R, LOHMANN SM, DEJONGE H, WALTER U, HOFMANN F: Insights from genetically modified mice cyclic GMP-dependent protein kinases and the cardiovascular system. Circ Res 93: 907-916, 2003.
19. FERRO CJ, WEBB DJ: Endothelial dysfunction and hypertension. Drugs 53: 30-41, 1997.
20. FEUERSTEIN GZ: Apoptosis - new opportunities for novel therapeutics for heart diseases. Cardiovasc Drugs Ther 15: 547-551, 2001.
21. FILIPOVIĆ D, KASAPOVIĆ J, PEJIĆ S, NICIFOROVIĆ A, PAJOVIĆ SB, RADOJČIĆ MB: Superoxide dismutase activity in various fractions of full bovine milk. Acta Aliment 3: 219-226, 2005.
22. GUISASOLA MC, DESCO MDEL M, GONZALEZ FS, ASENSIO F, DULIN E, SUAREZ A, GARCIA BARRENO P: Heat shock proteins, end effectors of myocardium ischemic preconditioning? Cell Stress Chaperones 11: 250-258, 2006.
23. GUO DF, SUN YL, HAMET P, INAGAMI T: The angiotensin II type 1 receptor and receptor-associated proteins. Cell Res 11: 165-180, 2001.
24. HALLIWELL B: Establishing the significance and optimal intake of dietary antioxidants: the biomarker concept. NutrRev 57: 104-113, 1999.
25. HASLER CM, KUNDRAT S, WOOL D: Functional foods and cardiovascular disease. Curr Atheroscler Rep 2: 467-475, 2000.
26. HOFFMAN RM, GAREWAL HS: Antioxidants and the prevention of coronary disease. Arch Intern Med 155: 241-246, 1995.
27. HOLVOET P: Endothelial dysfunction, oxidation of low-density lipoprotein, and cardiovascular disease. Ther Apher 3: 287-293, 1999.
28. HUANG RP, ADAMSON ED: Characterization of the DNA- binding properties of the early growth response-1 (ERG-1) transcription factor: evidence for modulation by a redox mechanism. DNA Cell Biol 12: 265-273, 1993.
29. HUTTER MM, SIEVERS RE, DARBOSA V, WOLFE CL: Heat-shock protein induction in rat hearts: a direct correlation between the amount of heat-shock protein induced and the degree of myocardial protection. Circulation 89: 355-360, 1994.
30. IMBERT V, RUPEC RA, LIVOLSI A, PAHL HL., TRAENCKNER BM., MUELLER-DIECKMANN C, FARAHIFA D, ROSSI B, AUBERGER P, BAEUERLE PA, PEYRON JF: Tyrosine phosphorylation of IκB activities NF-κB without proteolytic degradation of IκB-α. Cell 86: 787-798, 1996.
31. ISHII T, YANAGAWA T, YUKI K, KAWANE T, YOSHIDA H, BANNAI S: Low micromolar levels of hydrogen peroxide and proteasome inhibitors induce the 60-kDa A 170 stress protein in murine peritoneal macrophages. Biochem Biophys Res Commun 232: 33-37, 1997.
32. KANAZIR DT, RIBARAC-STEPIĆ N, DJORDJEVIĆ-MARKOVIĆ R, STEFANOVIĆ D, KATAN M, POPIĆ S, RADOJČIĆ M, KOVAČIĆ-MILIVOJEVIĆ; B: Extragenomic effects of glucocorticoids. In: Cell Function and Differentiation, C. Sekeris (ed.), Alan R. Liss, New York, 1982, pp 193-205.
33. KARIN M, HUNTER T: Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr Biol 5: 747-757, 1995.
34. KASAPOVIĆ J, PEJIĆ S, MLADENOVIĆ M, RADLOVIĆ N, PAJOVIĆ SB: Superoxide dismutase activity in colostrums, transitional and mature human milk. Turkish J Pediatr 47: 343-347, 2005.
35. KEYSE SM, EMSLIE EA: Oxidative stress and heat shock induce a human gene encoding a protein-tyrosin phosphatase. Nature 359: 644-647, 1992.
36. KIM J, NUEDA A, MENG XH, DYNAN WS, MIVERCHI NF: Analysis of the phosphorylation of human heat shock transcription factor-1 by MAP kinase family members. J Cell Biochem 67: 43-54, 1997.
37. KIYOSAWA I, MATUYAMA J, NYUI S, YOSHIDA K: Cu,Zn- and Mn-superoxide dismutase in human colostrum and mature milk. Biosci Biotech Biochem 57: 676-677, 1993.
38. 2. Proc Natl Acad Sci USA 94: 11233-11237, 1997.
39. KRSTEVSKA M, DZHEKOVA-STOJKOVA S, BOSILKPVA G: Menopause, coronary artery disease and antioxidants. Clin Chem Lab Med 39: 641-644, 2001.
40. KRSTIC MD, ROGATSKY I, YAMAMOTO KR, GARABEDIAN MJ: Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 17: 3947-3954, 1997.
41. LANDER HM: An essential role for free radicals and derived species in signal transduction. FASEB J 11: 118-24, 1997.
42. LIBBY P, RIDKER PM, MASERI A: Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
43. LIN SJ, SHYUE SK, HUNG YY, CHEN YH, KU HH, CHEN JW, TAM KB, CHEN YL: Superoxide dismutase inhibits the expression of vascular cell adhesion molecule-1 and intracellular cell adhesion molecule-1 induced by tumor necrosis factor-alpha in human endothelial cells through the JNK/p38 pathways. Arterioscler Thromb Vasc Biol 25: 334-340, 2005.
44. MAGIAKOU MA, SMYRNAKI P, CHROUSOS GP.: Hypertension in Cushing's syndrome. Best Pract Res Clin Endocrinol Metab 20: 467-482, 2006.
45. MARUI N, OFFERMANN MK, SWERLICK R, KUNSCH C, ROSEN CA, AHMAD M, ALEXANDER RW, MEDFORD RM: Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92: 1866-1874, 1993.
46. MCEWEN B: The End of Stress as We Know It. Joseph Henry Press, New York, 2002, 262 p.
47. MESTRIL R, CHI SH, SAYEN MR, O'REILLY K, DILLMANN WH, WOLFE CL: Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation 94: 1408-1411, 1996.
48. MICHELSON AM: Medical aspects of superoxide dismutase. In: Life Chemistry Reports. Harwood Academic Pub., United Kingdom, 1987, pp 1-142.
49. MYRSET AH., BOSTARD A, JAMIN N, LIRSAC PN, TOMA F, GABRIELSEN OS: DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein. EMBO J 12: 4625-4633, 1993.
50. NADEAU SI, LANDRY J: Mechanisms of activation and regulation of the heat shock-sensitive signaling pathways. Adv Exp Med Biol 594: 100-113, 2007.
51. NG MKC, CELERMAJER DS: Glucocorticoid treatment and cardiovascular disease. Heart 90: 829-830, 2004.
52. NUTTALL SL, KENDALL MJ, MARTIN U: Antioxidant therapy for the prevention of cardiovascular disease. QJM 92: 239-244, 1999.
53. PAJOVIĆ S., NIKEZIĆ G, MARTINOVIĆ JV: Effects of ovarian hormones on superoxide dismutase activity in rat brain synaptosomes. Neuroendocrinol Lett 16: 291-296, 1994.
54. PAJOVIĆ S, SAIČIĆ ZS, SPASIĆ MB, PETROVIĆ VM, MARTINOVI JV: Effects of progesterone and estradiol benzoate on superoxide dismutase activity in the brain of male rats. Experientia 52: 221-224, 1996.
55. PALMER HJ, PAULSON KE: Reactive oxygen species and antioxidants in signal transduction and gene expression. Nutr Rev 55: 353-361, 1997.
56. PARAVICINI TM, TOUYZ RM: Redox signaling in hypertension. Cardiovasc Res 71: 247-258, 2006.
57. PARTHASARATHY S, KHANMERCHANT N, PENUMETCHA M, SANTANAM: Oxidative stress in cardiovascular disease. J Nucl Cardiol 8: 379-389, 2001.
58. PINTHUS JH, TRACHTENBERG J, KLOTZ L: Cardiovascular effects of androgen depletion and replacement therapy. Urology 67: 1126-1132, 2006.
59. RAVINGEROVÁ T, BARANČÍK M, STRNISKOVÁ M: Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology. Mol Cell Biochem 247: 127-138, 2003.
60. SCHRECK R, RIEBER R, BAEUERELE PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
61. SELEZNEV YM, MARTINOV AV: Permissive effect of glucocorticoids in catecholamine action in the heart: possible mechanism. J Mol Cell Cardiol 14: 49-58, 1982.
62. SHACKELFORD RE, KAUFMANN WK, PAULES RS: Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 28: 1387-1404, 2000.
63. SIOW RCM, SATO H, MANN GE: Heme oxygenase carbon monoxide signaling pathway in atherosclerosis: antiatherogenic actions of bilirubin and carbon monoxide. Cardiovasc Res 41: 385-394, 1999.
64. TOLEDANO MB, LEONARD WJ: Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA 88: 4328-4332, 1991.
65. TORTI FM, TORTI SV: Regulation of ferritin genes and protein. Blood 99: 3505-3516, 2002.
66. TOUYZ RM, SCHIFFRIN EL: Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 122: 339-352, 2004.
67. UEYAMA T: Emotional stress-induced Tako-tsubo cardiomyopathy: animal model and molecular mechanism. Ann N Y Acad Sci 1018: 437-444, 1999.
68. USHIO-FUKAI M: Localizing NADPH oxidase-derived ROS. Sci STKE 349: re8, 2006.
69. USHIO-FUKAI M, ALEXANDER RW: Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264: 85-97, 2004.
70. WANG X, XU C, WANG X, WANG D, WANG Q, ZHANG B: Heat shock response and mammal adaptation to high elevation (hypoxia). Sci China C Life Sci 49: 500-512, 2006.
71. WHITE CR, DARLEYUSMAR V, OPARIL S: Gender and cardiovascular disease-recent insights. Trends Cardiovasc Med 7: 94-100, 1997.
72. WHITWORTH JA., MANGOS GJ, KELLY JJ: Cushing, cortisol, and cardiovascular disease Hypertension 36: 912-916, 2000.
73. YUNG LM, LEUNG FP, YAO X, CHEN ZY, HUANG Y: Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets 6: 1-19, 2006.